| Literature DB >> 29966381 |
Ching-Chang Cho1, Wen-Yeh Hsieh2, Chin-Hung Tsai3,4, Cheng-Yi Chen5,6, Hui-Fang Chang7,8, Chih-Sheng Lin9.
Abstract
Air pollution is a very critical issue worldwide, particularly in developing countries. Particulate matter (PM) is a type of air pollution that comprises a heterogeneous mixture of different particle sizes and chemical compositions. There are various sources of fine PM (PM2.5), and the components may also have different effects on people. The pathogenesis of PM2.5 in several diseases remains to be clarified. There is a long history of epidemiological research on PM2.5 in several diseases. Numerous studies show that PM2.5 can induce a variety of chronic diseases, such as respiratory system damage, cardiovascular dysfunction, and diabetes mellitus. However, the epidemiological evidence associated with potential mechanisms in the progression of diseases need to be proved precisely through in vitro and in vivo investigations. Suggested mechanisms of PM2.5 that lead to adverse effects and chronic diseases include increasing oxidative stress, inflammatory responses, and genotoxicity. The aim of this review is to provide a brief overview of in vitro and in vivo experimental studies of PM2.5 in the progression of various diseases from the last decade. The summarized research results could provide clear information about the mechanisms and progression of PM2.5-induced disease.Entities:
Keywords: PM2.5; animal model; disease progression; in vitro study; particulate matter (PM)
Mesh:
Substances:
Year: 2018 PMID: 29966381 PMCID: PMC6068560 DOI: 10.3390/ijerph15071380
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1The potential mechanisms of PM The cellular toxicity components, mainly including free radicals, organic chemicals, and transition metals, of PM2.5 may induce or produce reactive oxygen species (ROS) that impair the cellular physiological/biochemical processes by the mechanisms of inducing oxidative stress, inflammation, genotoxicity, and others, altering the normal physiological functions and/or fates of target cells, resulting in damage of the tissues and organs.
Summary of in vitro studies for the effects of PM2.5 treatment on cell responses and damages.
| Diseases | Cell Line | Dosage | Cell Cultured Method | Study Findings and/or Conclusion | Reference |
|---|---|---|---|---|---|
| BEAS-2B | 50 mg/mL | submerged | Organic fraction of PM2.5 causes micronucleus formation and DNA breakage leads to inhibition of antioxidant enzymes, which increases the oxidative stress. | [ | |
| 25, 50, and 100 µg/mL | submerged | PM2.5 enhances autophagy via PI3K/Akt/mTOR pathway inhibition. | [ | ||
| 1.5, 3, and 6 μg/cm2 | submerged | PM2.5 inhibits the P53 levels through ROS-Akt-DNMT3B pathway-related p53 promoter hypermethylation. | [ | ||
| 2.5, 5, and 10 μg/cm2 | submerged | PM2.5 induces expression of the IL-8 gene by endocytosis and oxidative stress induction. | [ | ||
| 0.1 mg/mL | air-liquid interface | Secondary organic aerosol-PM2.5 downregulates the expression and activation of Nrf2-related transcription factor system. | [ | ||
| 289.4 μg/m3 | air-liquid interface | Motorcycle exhaust-PM exposure reduces cell relative viabilities and induces ROS generation | [ | ||
| 16HBE cells | 50 and 100 μg/mL | submerged | PM2.5 can regulate JAK/STAT signaling pathway leading to oxidative damage of cells | [ | |
| 50 µM/cm2 | submerged | PM2.5 induces the Der p1 antigen-related innate immune response via the increasing of IL-25, IL-33, and TSLP levels. | [ | ||
| 16, 32, 64, and 128 mg/mL | submerged | PM2.5 induces oxidative damage, DNA strand breaks, and apoptosis occurs by the p53-dependent pathway. | [ | ||
| 100 mg/mL | submerged | PM2.5 elevates ROS generation, and inhibits mitochondrial genes expressions, resulting in mitochondrial damage and apoptosis. | [ | ||
| Human AM/L132 | 18.84, 37.68, 56.52, 75.36, and 150.72 μg/mL | submerged | PM2.5-0.3 induces genetic instability and alterations of cell cycle via TP53-RB gene signaling pathway activation in the human alveolar macrophage and L132 co-culture model | [ | |
| BEAS-2/THP-1 | 10 and 100 μg/mL | submerged | Industrial PM2.5 extracts enhance inflammation and pulmonary epithelial cells injuries via the RhoA/ROCK-dependent NF-кB signaling pathway. | [ | |
| HBEC | 100 μg/mL | air-liquid interface | PM2.5 enhances arginase II levels via the EGF-related signaling pathway of oxidative stress and expression in human bronchial epithelial cells. | [ | |
| 1, 10, and 100 μg/cm2 | air-liquid interface | PM2.5 elevates the tetra-OH-B[a]P and 8-OHdG levels in the DNA of primary human bronchial epithelial (HBE) cells from COPD patients compared to those in HBE from normal subjects. | [ | ||
| PBEC | 1.1, 2.2, 5.6, and 11.1 μg/cm2 | air-liquid interface | Transition metals of PM increase the levels of IL-8 and HO-1, leading to ROS production in mucus-secreting ALI-cultured primary bronchial epithelial cells. | [ | |
| A549 | _ | submerged | 10 transition metals and 16 critical PAHs were analyzed in PM2.5 samples, and their biological effects included the induction of cell death and the reduction of cell viability | [ | |
| 50, 100, and 200 μg/mL | submerged | Organic and aqueous fraction of PM extracts inhibit cell proliferation by PM2.5 and induces LDH release by PM10. | [ | ||
| 25, 50, 100, 200, 300, and 600 μg/mL | submerged | PM2.5 upregulates the metal-redox-sensitive transcription factors, NF-κβ and AP-1 in apoptosis. | [ | ||
| 100 μg/mL | submerged | PM2.5-induces autophagy via the AMP-activated protein kinase signaling pathway. | [ | ||
| 50 and 100 μg/mL | submerged | PM2.5-induces ROS increases ICAM-1 levels through the IL-6/Akt/STAT3/NF-κB axis. | [ | ||
| 75 μg/mL | submerged | Cooking oil fumes-PM2.5 can lead A549 cells to apoptosis and inflammation that might be through the activation of the MAPK/NF-кB/STAT1 signaling pathway. | [ | ||
| 12.5, 25, 50, 100, and 200 μg/mL | submerged | PM2.5 enhances oxidative stress and cell cycle alteration in theG2/M phase that is associated with increased p53 and p21 levels and decreased CDK1 mRNA expression in A549 cells. | [ | ||
| A549/THP-1 | 10 μg/cm2 | submerged | PM0.4 and PM1 induce ROS generation and double strand DNA breaks in A549 and THP-1 cells co-culture model that may correlate with the exacerbation of respiratory diseases. | [ | |
| Cardiovascular dysfunctions | EA.HY926 | 0.01, 0.1 and 1 mg/cm2 | submerged | Metal ions of PM2.5 cause oxidative stress, resulting in PM2.5-mediated mitochondrial apoptosis via the NF-κB pathway. | [ |
| 0,20, 200, 400 mg/L | submerged | PM2.5 stimulates oxidative stress and inflammation in endothelial cells; ERK1/2 is involved in the signaling pathway. | [ | ||
| 10, 25, and 50 μg/mL | submerged | Coal-fired PM2.5 has the potency to reduce cell viability, induce oxidative DNA damage, and global DNA methylation. | [ | ||
| 25, 50, 100, and 200 μg/mL | submerged | PM2.5-induced ROS enhances VCAM-1 and ICAM-1 levels via the ERK/Akt/NF-κB axis that leads to monocyte adhesion to endothelial cells. | [ | ||
| HUVEC/U937 | 5, 10, 20, and 40 μg/cm2 | submerged | PM2.5 and PM10 enhance monocytic adhesion via the expression of adhesion molecules, such as E-selectin, P-selectin, and ICAM-1, in the development of inflammatory responses, which may evaluate the progression of atherosclerosis | [ | |
| H9c2 cells | 100, 200, 400 and 800 μg/mL | submerged | PM2.5 induces cell death and reduces cell viability via triggering of the MAPK signaling pathway and increasing intracellular ROS generation. | [ | |
| Immune inflammatory responses | RAW 264.7 | _ | submerged | PM2.5 collected from six European cities increases the levels of chemokine (macrophage inflammatory protein 2), proinflammatory factors (TNF-α and IL-6), and NO production, and caused cytotoxicity. | [ |
| _ | submerged | Transition metals (Co, Cu, V and Ni) of PM2.5 significantly induces ROS levels. | [ | ||
| _ | submerged | Organic fractions of PM2.5 display Cyp1A1 activation and higher mutagenicity and led to greater activation of TNF-α release. | [ | ||
| 25, 50, and 100 μg /mL | submerged | PM2.5 induces autophagy of pulmonary macrophages via the oxidative stress-mediated PI3K/AKT/mTOR pathway. | [ | ||
| 30 μg /mL | submerged | PM2.5 induces NF-κB and p38 levels, leading to enhanced proinflammatory factors, and MCP-1 and TNF-αexpression, which triggers inflammatory responses. | [ | ||
| 50, 100, and 200 mg/mL | submerged | PM2.5 induces NO release and increases levels of LDH and intracellular ROS. | [ | ||
| 100 μg/mL | submerged | Aqueous and organic fractions of PM2.5 induce expression of IL-1β through the TLR4/NF-κB axis, conducive to nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome formation. | [ | ||
| CD4+ T/ DC | 50 µg/mL | submerged | PM2.5 enhances the activation of dendritic cells and Th17-immune responses through the aryl hydrocarbon receptor-dependent pathway. | [ |
Summary of in vivo studies on health effects of PM2.5.
| Health Effects | Animal Models | PM2.5 Dosage | Methods of PM2.5 Treatment | Study Findings and/or Conclusion | Reference |
|---|---|---|---|---|---|
| Respiratory diseases | C57BL/6 mice | 5 and 15 μg/mouse | Instillation | Low doses of PM2.5 may simulate histological and functional changes in lung tissue, but do not impact oxidative stress and inflammations. Acute PM2.5 exposure enhances pulmonary oxidative stress, inflammatory responses, and deteriorated pulmonary impedance. | [ |
| 6 h/day, 5 days/week for 5, 14, and 21 days | Inhalation | PM2.5 induces MCP-1 and neutrophils levels in pulmonary inflammation. | [ | ||
| 6.25 mg/kg/day, once a day for 3 days | Instillation | ACE2 deficiency enhances inflammatory responses and tissue remodeling through p-STAT3 and p-ERK1/2 signaling pathways in PM2.5-induced acute lung injury. | [ | ||
| 2.5, 5, and 10 mg/kg/mouse | Instillation | Acute PM2.5 exposure triggered the Th2-mediated immune response and leads to locally and systemically acute inflammations in mice. | [ | ||
| Wistar rats | 0.3, 1.0, and 3.0 μg /mL | Instillation | PM2.5 upregulates endothelin A receptors and endothelin B receptors, and are associated with JNK and p38 pathways and MEK1/2 and p38 pathways in rat bronchi. | [ | |
| 0.4 mg/mL/rat | Inhalation | PM2.5 can significantly enhance changes of Cyclin-dependent kinase 2 and p53 in the early phase, cyclin B and Cell Cycle Controller 2 in mid-term, and p21 in long-term exposure. | [ | ||
| 8 mg/rat | Instillation | PM2.5 exposure significantly induces the expression level of SOD, IL-6 and IL-8, and neutrophil under cold stress. | [ | ||
| 0.3, 0.75, 2, and 5 mg/rat | Instillation | PM2.5 can induce the inflammation response and reduce the phagocytic activity of alveolar macrophages, resulting in lung injuries in female rats. | [ | ||
| 0.375, 1.5, 6.0, and 24.0 mg/kg (body weight) | Inhalation | PM2.5-induced pathological injury is related to ROS production, mitochondrial fusion–fission dysfunction, mitochondrial lipid peroxidation, and abnormal cellular homeostasis | [ | ||
| 0.1, 0.5, 2.5, and 7.5 mg/kg | Intraperitoneal instillation | Maternal PM2.5 may upregulate the epithelial-mesenchymal transition ion through the TGF-β/Smad3 signaling pathway in postnatal pulmonary dysfunction. | [ | ||
| Cardiovascular dysfunction | Balb/c mice | 10 mg/kg | Instillation | PM2.5 increases T helper 17-mediated viral replication, perforin response, and imbalance of MMP-2/TIMP-1 in virus-induced myocarditis. | [ |
| 10 mg/kg | Instillation | PM2.5 induces T regulatory cells (Treg) responses in virus-induced myocarditis. | [ | ||
| 0.3 mg/mouse | Instillation | PM2.5 exposure induces HO-1, ET-1, Cyp1A1, Cyp1B1 myeloperoxidase, and Hsp70 levels of lung and heart. | [ | ||
| Apoe(-/-) mice | 6 h/day, 5 days/week for 6 months | Inhalation | Ni and P of PM2.5 may correlate with heart rate and heart rate variability. Long-range transported PM2.5 may positively associate with heart rate and negatively with heart rate variability. | [ | |
| 3, 10, and 30 mg/kg | Instillation | PM2.5 can significantly enhance malondialdehyde and reduce heart rate variability in atherosclerosis. | [ | ||
| 24 h/day, 7 days/week, for 2 months | Inhalation | PM2.5 can upregulate the visfatin to activate the inflammation, oxidative stress and accelerate the atherosclerosis. | [ | ||
| 6 h/day, 5 days/week for 3 months | Inhalation | PM2.5 induces CD36-dependent 7-ketocholesterol accumulation in macrophages on the progression of atherosclerosis. | [ | ||
| Kkay mice | 6 h/day, 5 day/week for 8 weeks | Inhalation | IKK/NFκB pathway also plays a critical role in mediating PM2.5-related cardiovascular impairment in a type 2 diabetes mellitus mice model. | [ | |
| Wistar rats | 0.2, 0.8, and 3.2 mg/rat | Instillation | PM2.5 alone exposure induces inflammation, endothelial function, and ANS injuries, and ozone potentiated these effects induced by PM2.5. | [ | |
| SD rats | 10 h/day for 4 or 5 consecutive days | Inhalation | PM2.5 exposure depresses cardiovascular system with diet-induced metabolic syndrome. | [ | |
| 0.375, 1.5, 6, and 24 mg/kg | Instillation | PM2.5 induces oxidative stress, inflammation, and calcium homeostasis disorder, resulting in mitochondrial damage. | [ | ||
| 0, 0.3, 1, and 3 mg/mL for 24 h | Instillation | PM2.5 induces the endothelin B and endothelin A receptor upregulation via the MEK/ERK1/2 pathway in rat coronary arteries. | [ | ||
| 10 mg/mL/day for 7 days | Nasal Inoculation | PM2.5 might exaggerate neurobehavioral alterations that are associated with astrocytes activation and inflammatory reactions in ischemic stroke of SD male rats. | [ | ||
| Diabetes mellitus | C57BL/6 mice | 6 h/day, 5 days/week for 10 months | Inhalation | Chronic PM2.5 exposure enhances gene expression, mitochondrial alterations, and oxidative stress in brown and white adipose tissues. | [ |
| 6 h/day, for 9 or 30 consecutive days | Inhalation | PM2.5 induces NF-κB-related inflammasome activation and vascular insulin resistance leads to peripheral blood and bone marrow endothelial progenitor cells level recovery. | [ | ||
| 6 h/day, 5 days/week for 10 months | Inhalation | Chronic PM2.5 exposure induces macrophage infiltration and Unfolded Protein Response in white adipose tissue. | [ | ||
| 6 h/day, 5 days/week for 17 weeks | Inhalation | PM2.5 enhances insulin resistance through regulation of hepatic lipid metabolism, visceral adipose tissue inflammatory responses, and glucose utilization in skeletal muscle through both CCR2-dependent and -independent pathways in HFD-fed mice. | [ | ||
| B6.129SF2/J mice | 5 μg/day/mouse for 12 weeks | Instillation | PM2.5 promotes [eHsp72]/[iHsp70] and the cell stress response, leading to an increased risk of metabolic dysfunction and type 2 diabetes mellitus in HFD-fed mice | [ | |
| SD rats | 24 h/day, 7 days/week, for 16 weeks. | Inhalation | PM2.5 exposure significantly elevates the levels of glycated hemoglobin A1c, IL-6, and fibrinogen, which lead to the deterioration of tubular injury, glomerulosclerosis, aortic medial thickness, and focal myocarditis in the kidney and heart. | [ | |
| 5 h/day for 3 days | Inhalation | PM2.5 exposure increases the angiotensin/bradykinin systems, immune, and antioxidant imbalance in early kidney damage. | [ | ||
| 3 and 30 μg/mouse | Instillation | Long-Term PM2.5 increases blood pressure by inhibition of the D1 receptor through regulation of the G protein-coupled receptor, kinase 4 | [ | ||
| 15 mg/kg, cumulative dose is 30 mg/kg | Instillation | PM2.5 reduces levels of GSH-Px and induced malondialdehyde, resulting in an oxidative response and inflammation in the pancreas, and pancreatic GLUT2 levels declined. | [ | ||
| Allergic sensitization | NC/Nga mice | Supernatant fraction: 50 μg; precipitate fraction: 200 μg | Nasal Inoculation | PM2.5 can enhance airway hyperresponsivness in mice through an inflammasome activation and synergistic action of insoluble and soluble fractions of PM2.5. | [ |
| Balb/c mice | 1, 10, and 100 μg/mouse | Instillation | PM2.5 can synergize with allergens to exacerbate the progression of asthma via activation of the Th2-related immune response. | [ | |
| 100 μg/mouse | Intraperitoneal injection | PM2.5 and formaldehyde co-exposure can induce oxidative stress to significantly exacerbate allergic asthma via the transient receptor potential vanilloid 1 pathway. | [ | ||
| 10, 31.6, or 100 µg/mouse | Instillation | PM2.5 exacerbates allergic airway inflammation via thymic stromal lymphopoietin activation. | [ | ||
| 33.3 µg/mouse | Instillation | PM2.5 and allergens from dust mites enhance the hyper-responsiveness of the airway through the activation of T-helper cell type 17 activation. | [ | ||
| Guinea pig | 1.1 ± 0.2 kg/chamber | Inhalation | Acute PM2.5 exposure with aluminum hydroxide in sensitized animals enhances the specific-hyperresponsiveness and eosinophilic and neutrophilic airway inflammation in allergic asthma. | [ |
Strengths and weaknesses of intratracheal inhalation and intratracheal instillation on PM2.5 exposure to experimental rodents.
| Methods | Intratracheal Instillation | Intratracheal Inhalation |
|---|---|---|
| Operative difficulty | High | Low |
| Equipment cost | Low | High |
| Dosage | Instillated dosage (mg/kg of body weight or mg/animal). | Real deposition in the respiratory system of animal model. Defined by the PM2.5 concentration (mg/m3) |
| Deposition | Uneven distribution in the lung lobes | Evenly distributed in the lung lobes |
| Effects for animal | More severe | Less severe |